Skip to content
healthcare.dev

Sildenafil

NDC 82647-210, sildenafil, tablet, film coated, from Reyoung Corporation.

Product NDC
82647-210
Status
Listed
Labeler
Reyoung Corporation
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208494
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82647-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SILDENAFIL CITRATE25 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
82647-210-14826470210141000 TABLET, FILM COATED in 1 BOTTLE (82647-210-14)
82647-210-308264702103030 TABLET, FILM COATED in 1 BOTTLE (82647-210-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dc998a9c-0770-111b-e053-2a95a90a88a4

Use it

Look up 82647-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82647-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82647-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.